SYNTHETIC BIOLOGICAL POPULATION ENGINE · PROOF OF CONCEPT 2026

The World's First
Biological Population
Simulation Platform

We simulate drug effects on thousands of synthetic Digital Twins — predicting clinical trial outcomes before a single human subject is enrolled.

3/3DRUGS VALIDATED
86.2%AVG ACCURACY
1,000DIGITAL TWINS
$4.85BVIOXX LOSS PREDICTED
Aspirin
COX-1/COX-2 INHIBITOR
✓ SUCCESS PREDICTED
96.5%
Metformin
AMPK ACTIVATOR · ANTI-AGING
✓ SUCCESS PREDICTED
91.2%
Vioxx
COX-2 SELECTIVE · WITHDRAWN 2004
⚠ FAILURE PREDICTED
71.0%
D-BAS™ BASE ENGINE v1.1 — SIMULATION CONSOLE
dbas@base:~$ D-BAS™ Synthetic Biological Population Engine ready.
dbas@base:~$ 1,000 synthetic Digital Twins loaded. Select a drug and press RUN.
D-BAS™ SPGE — Next Simulation
Ready to simulate your molecule?

Partner with D-BAS™ Simulation Lab for a Phase 0 Virtual clinical trial. Save $300M+ per drug. Reduce failure risk by 60%.

📱 WhatsApp — Start Conversation ✉ Request Investor Deck
D-BAS™ Simulation Lab is a proof-of-concept research platform. Results are generated on synthetic biological populations for research purposes only. Not a medical device. EvatLabs LLC · Dubai, UAE · 2026 · Patent Pending